Regulatory Submission Readiness: 12 Gaps That Cause Last-Minute Rework
Find twelve preventable submission-writing readiness gaps, with evidence, ownership, and stop/conditional/clear criteria before a filing.
IND Module 2 Writing: Aligning Quality, Nonclinical, and Clinical Summaries
Use a source-to-summary concordance matrix to align IND Module 2 quality, nonclinical, and clinical statements before regulatory review.
Clinical Trial Change Orders: How to Control Scope, Cost, and Approval
Clinical trial change orders should document why scope changed, the effect on participants/data/timeline, the incremental cost, and who is authorized to approve it. The change-control log prevents a series of small vendor changes from silently moving the trial budg
Phase I Clinical Trial Project Plan: Key Milestones From Startup Through Closeout
A Phase I trial project plan should connect sponsor decisions and vendor deliverables from protocol readiness through startup, first patient, cohort execution, database lock and closeout. Owners and dependencies matter more than a decorative Gantt chart.
eCRF Design Mistakes That Increase Queries, Site Burden, and Data Cleaning
eCRF mistakes increase site workload and threaten data quality when questions are redundant, labels ambiguous, controls overly strict or source data difficult to map. A design review should quantify the likely correction burden before deployment.
Protocol Amendments and EDC Changes: How to Control Database Impact
Protocol amendments can change database structure, data collection, edit checks and downstream analyses. Use a controlled impact assessment that addresses participants already enrolled, current forms, historical data and site retraining before releasing EDC changes
EDC Build Timeline for a Phase I Study: Key Decisions, Reviews, Testing, and Release
A Phase I EDC build timeline is driven by protocol stability, database specifications, integration readiness, UAT completion and release approval. A sample schedule can guide internal planning, but its durations are not regulatory deadlines.
Common Data Management Plan Gaps in Outsourced Clinical Trials
Outsourced clinical data management plans often fail at interfaces rather than core tasks. Sponsors should review cross-vendor responsibilities, external data timing, safety reconciliation, change impact and lock acceptance rather than accepting an attractive gener
Data Management Plan Readiness Before EDC Build: What Must Be Decided First
A data management plan should reach a decision-ready baseline before EDC programming begins. Open questions about endpoints, visit schedules, coding, external data and source provenance tend to become costly rework once database specifications are built.
GCP Audit Findings: Classification, Response, CAPA, and Follow-Up
GCP audit findings need objective evidence, a defensible assessment of risk and scope, clear response ownership, and verification that remediation worked. Internal severity categories should be defined by the audit program and must not be represented as FDA inspect